(204) National Trends in the Treatment of Fournier's Gangrene: 2016-2019

I Su,J Marte,J Lee,D Han,J Kurtzman,G Joice
DOI: https://doi.org/10.1093/jsxmed/qdae001.194
2024-02-07
The Journal of Sexual Medicine
Abstract:Introduction Fournier's gangrene (FG) is a surgical emergency with significant inpatient mortality and long-term morbidity. Population-based databases such as the National Inpatient Sample (NIS) are valuable tools in investigating rare conditions, yet no recent studies have looked at trends and outcomes of FG at a national level. An increasing burden of this disease may be placed on large academic centers due to regional demographics and hospital transfer to these centers for specialized expertise. Objective To evaluate national trends in the management of FG to identify predictive factors of in-hospital mortality or inter-hospital transfer. Methods All patients hospitalized with FG between 2016-2019 were extracted from the NIS using the International Classification of Diseases (10th Revision) Diagnosis Code N49.3. Stratified cluster sampling was used to create weighted national estimates. The primary combined outcome was the proportion of patients who died during hospitalization or required inter-hospital transfer. Multivariable logistic regression was performed to identify predictors of this outcome. Results Between 2016 and 2019, there were an estimated 21,715 inpatients treated for FG in the US. There was an 8.5% increase in the patients treated yearly over the study period. The average age was 45.8 years, the average length of stay was 10.8 days, and the average total charge of hospitalization was $127,140. Overall, 4.3% of patients died during hospitalization and 7.2% were transferred to another short-term hospital facility. The region with the highest prevalence was the South (44.8%) and most admissions were to urban teaching hospitals (72.6%). Significant predictors of the combined outcome of in-hospital mortality or inter-hospital transfer included older age, non-private insurance, and greater Elixhauser Comorbidity Index (p<0.05). Protective factors included medium/high volume hospital, urban setting (vs. rural), Midwest/Southern region (vs. Northeast), and 2nd or 3rd cost tertile (vs. 1st tertile) (p<0.05) [Table]. Conclusions We highlight an association of poor outcomes from FG with non-private insurance in older adults with more comorbidities. We also noted an increased burden of FG patients at large, urban teaching facilities due to regional demographics and inter-hospital transfer. Further work needs to be done to determine how inter-hospital transfer and potential delays in life-saving surgical debridement affect outcomes in FG. Disclosure No.
urology & nephrology
What problem does this paper attempt to address?